Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MINI-STAR Trial
KCT0012722Phase 4Not yet recruiting
- Sponsor
- Daewoong Pharmaceutical
- Start
- Nov 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin, atorvastatin, pitavastatin, ezetimibe in atherosclerosis, sponsored by Daewoong Pharmaceutical. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
rosuvastatinatorvastatinpitavastatinezetimibe
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on KCT0012722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0012722.